{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:57:21Z","timestamp":1790251041104,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"The EUROASPIRE IV and V"},{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EURObservational Research Programme"},{"name":"European Society of Cardiology from Amgen"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol\u2013Myers Squibb\/Emea Sarl"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hoffmann\u2013La Roche and Merck"},{"name":"Sharp & Dohme (EUROASPIRE IV) and Amarin"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ferrer"},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims\u2003<\/jats:title>\n                    <jats:p>Despite the high use of cardioprotective medications, the risk factor control in patients with coronary heart disease (CHD) is still inadequate. Guidelines identify healthy lifestyles as equally important in secondary prevention as pharmacotherapy. Here, we describe reasons for poor lifestyle adherence from the patient\u2019s perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results\u2003<\/jats:title>\n                    <jats:p>In the EUROASPIRE IV and V surveys, 16 259 CHD patients were examined and interviewed during a study visit \u22656\u2009months after hospital discharge. Data gathering was fully standardized. The Brief Illness Perception questionnaire was completed by a subsample of 2379 patients. Half of those who were smoking prior to hospital admission, were still smoking; 37% of current smokers had not attempted to quit and 51% was not considering to do so. The prevalence of obesity was 38%. Half of obese patients tried to lose weight in the past month and 61% considered weight loss in the following month. In relation to physical activity, 40% was on target with half of patients trying to do more everyday activities. Less than half had the intention to engage in planned exercise. Only 29% of all patients was at goal for all three lifestyle factors. The number of adverse lifestyles was strongly related to the way patients perceive their illness as threatening. Lifestyle modifications were more successful in those having participated in a cardiac rehabilitation and prevention programme. Patients indicated lack of self-confidence as the main barrier to change their unhealthy behaviour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion\u2003<\/jats:title>\n                    <jats:p>Modern secondary prevention programmes should target behavioural change in all patients with adverse lifestyles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwab115","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T15:15:34Z","timestamp":1623338134000},"page":"383-395","source":"Crossref","is-referenced-by-count":91,"title":["Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-7238","authenticated-orcid":false,"given":"Dirk","family":"De Bacquer","sequence":"first","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Astin","sequence":"additional","affiliation":[{"name":"Centre for Applied Research in Health, University of Huddersfield and Calderdale & Huddersfield NHS Foundation Trust, Huddersfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Kotseva","sequence":"additional","affiliation":[{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland"},{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-804X","authenticated-orcid":false,"given":"Nana","family":"Pogosova","sequence":"additional","affiliation":[{"name":"National Medical Research Centre of Cardiology, Ministry of Healthcare of the Russian Federation, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"De Smedt","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"De Backer","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10-6K3, entrance 42, B-9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Jennings","sequence":"additional","affiliation":[{"name":"National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland"},{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the EUROASPIRE IV and V surveys of the European Observational Research Programme of the European Society of Cardiology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2022031209203632300_zwab115-B1","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/eurheartj\/ehn478","article-title":"Modifiable risk factors control and its relationship with 1-year outcomes after coronary artery bypass surgery: insights from the REACH registry","volume":"29","author":"Mehta","year":"2008","journal-title":"Eur Heart J"},{"key":"2022031209203632300_zwab115-B2","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull World Health Organ"},{"key":"2022031209203632300_zwab115-B3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/2047487312444995","article-title":"Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study","volume":"20","author":"Vedin","year":"2013","journal-title":"Eur J Prev Cardiology"},{"key":"2022031209203632300_zwab115-B4","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.2013.3519","article-title":"Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study","volume":"309","author":"Teo","year":"2013","journal-title":"JAMA"},{"key":"2022031209203632300_zwab115-B5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"2022031209203632300_zwab115-B6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry","volume":"22","author":"Ferrari","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209203632300_zwab115-B7","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022031209203632300_zwab115-B8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1559827616651402","article-title":"Lifestyle modification in secondary prevention: beyond pharmacotherapy","volume":"11","author":"Brinks","year":"2017","journal-title":"Am J Lifestyle Med"},{"key":"2022031209203632300_zwab115-B9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","article-title":"Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE Surveys, 1999-2013","volume":"12","author":"Kotseva","year":"2017","journal-title":"Glob Heart"},{"key":"2022031209203632300_zwab115-B10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209203632300_zwab115-B11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209203632300_zwab115-B12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psych Scand"},{"key":"2022031209203632300_zwab115-B13"},{"key":"2022031209203632300_zwab115-B14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"key":"2022031209203632300_zwab115-B15","volume-title":"Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling","author":"Snijders","year":"1999","edition":"1st edn"},{"key":"2022031209203632300_zwab115-B16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10618600.1992.10477011","article-title":"The factor analytic approach to simultaneous inference in the general linear model","volume":"1","author":"Hsu","year":"1992","journal-title":"J Comput Graph Stat"},{"key":"2022031209203632300_zwab115-B17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.115.019634","article-title":"Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome","volume":"133","author":"Eisenberg","year":"2016","journal-title":"Circulation"},{"key":"2022031209203632300_zwab115-B18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.280","article-title":"Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial","volume":"313","author":"Ebbert","year":"2015","journal-title":"JAMA"},{"key":"2022031209203632300_zwab115-B19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/08870446.2015.1070851","article-title":"A systematic review and meta-analysis of the Brief Illness Perception Questionnaire","volume":"30","author":"Broadbent","year":"2015","journal-title":"Psychol Health"},{"key":"2022031209203632300_zwab115-B20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"2022031209203632300_zwab115-B21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/add.15056","article-title":"Behaviour change techniques associated with smoking cessation in intervention and comparator groups of randomized controlled trials: a systematic review and meta-regression","volume":"115","author":"Black","year":"2020","journal-title":"Addiction"},{"key":"2022031209203632300_zwab115-B22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/08870446.2010.540664","article-title":"A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy","volume":"26","author":"Michie","year":"2011","journal-title":"Psychol Health"},{"key":"2022031209203632300_zwab115-B23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000484933","article-title":"Health behavior change for obesity management","volume":"10","author":"Teixeira","year":"2017","journal-title":"Obes Facts"},{"key":"2022031209203632300_zwab115-B24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1037\/0003-066X.37.2.122","article-title":"Self-efficacy mechanism in human agency","volume":"37","author":"Bandura","year":"1982","journal-title":"Am Psychol"},{"key":"2022031209203632300_zwab115-B25","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/jnr.0000000000000336","article-title":"Readiness for behavior change in patients living with ischemic heart disease","volume":"27","author":"Eshah","year":"2019","journal-title":"J Nurs Res"},{"key":"2022031209203632300_zwab115-B26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/clc.23272","article-title":"Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: assessing patient interest, confidence, and physician prescribing practices","volume":"42","author":"Riley","year":"2019","journal-title":"Clin Cardiol"},{"key":"2022031209203632300_zwab115-B27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1090198117712333","article-title":"Social support for changing multiple behaviors: factors associated with seeking support and the impact of offered support","volume":"45","author":"Greaney","year":"2018","journal-title":"Health Educ Behav"},{"key":"2022031209203632300_zwab115-B28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjhp.12227","article-title":"Health behaviour change interventions for couples: A systematic review","volume":"22","author":"Arden-Close","year":"2017","journal-title":"Br J Health Psychol"},{"key":"2022031209203632300_zwab115-B29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2648.2008.04836.x","article-title":"Primary angioplasty for heart attack: mismatch between expectations and reality?","volume":"65","author":"Astin","year":"2009","journal-title":"J Adv Nurs"},{"key":"2022031209203632300_zwab115-B30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/heartjnl-2016-310750","article-title":"Heart and mind: behavioural cardiology demystified for the clinician","volume":"105","author":"Astin","year":"2019","journal-title":"Heart"},{"key":"2022031209203632300_zwab115-B31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","article-title":"Depression and cardiovascular disease: a clinical review","volume":"35","author":"Hare","year":"2014","journal-title":"Eur Heart J"},{"key":"2022031209203632300_zwab115-B32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12160-016-9777-9","article-title":"Direction of association between depressive symptoms and lifestyle behaviours in patients with CHD: the Heart and Soul Study","volume":"50","author":"Sin","year":"2016","journal-title":"Ann Behav Med"},{"key":"2022031209203632300_zwab115-B33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpsychores.2016.09.003","article-title":"Identifying psychosocial predictors of medication non-adherence following ACS: a systematic review and meta-analysis","volume":"90","author":"Crawshaw","year":"2016","journal-title":"J Psychosom Res"},{"key":"2022031209203632300_zwab115-B34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487312449597","article-title":"Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology","volume":"21","author":"Piepoli","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209203632300_zwab115-B35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2016.12.125","article-title":"Lessons from contemporary trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis","volume":"232","author":"van Halewijn","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022031209203632300_zwab115-B36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.89.3.975","article-title":"Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease The Stanford Risk Intervention Project (SCRIP)","volume":"89","author":"Haskell","year":"1994","journal-title":"Circulation"},{"key":"2022031209203632300_zwab115-B37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-120-9-199405010-00001","article-title":"A case-management system for coronary risk factor modification after acute myocardial infarction","volume":"120","author":"DeBusk","year":"1994","journal-title":"Ann Intern Med"},{"key":"2022031209203632300_zwab115-B38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(08)60868-5","article-title":"Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial","volume":"371","author":"Wood","year":"2008","journal-title":"Lancet"},{"key":"2022031209203632300_zwab115-B39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/heartjnl-2013-303989","article-title":"Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE randomised trial","volume":"99","author":"Jorstad","year":"2013","journal-title":"Heart"},{"key":"2022031209203632300_zwab115-B40","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1001\/archinte.163.22.2775","article-title":"Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease","volume":"163","author":"Vale","year":"2003","journal-title":"Arch Intern Med"},{"key":"2022031209203632300_zwab115-B41","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/heartjnl-2016-310477","article-title":"Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme","volume":"103","author":"Connolly","year":"2017","journal-title":"Heart"},{"key":"2022031209203632300_zwab115-B42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/2047487313498831","article-title":"Translating guidelines to practice: findings from a multidisciplinary preventive cardiology programme in the west of Ireland","volume":"21","author":"Gibson","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209203632300_zwab115-B43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2047487319865729","article-title":"Cardiac rehabilitation after acute myocardial infarction in Sweden - evaluation of programme characteristics and adherence to European guidelines: the Perfect Cardiac Rehabilitation (Perfect-CR) study","volume":"27","author":"\u00d6gmundsdottir Michelsen","year":"2020","journal-title":"Eur J Prev Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/2\/383\/42855237\/zwab115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/2\/383\/42855237\/zwab115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T11:54:36Z","timestamp":1725191676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/29\/2\/383\/6323663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2022,3,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwab115","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,7,19]]}}}